Skip to main content

Vaccine and Procedure Costs: Usable Doses, Supplies and Cold Chain

Calculate the cost of a vaccine or procedure from the resources actually used, the stock still usable and the losses or uncertainties recorded separately. Include consumables, staff time, cold-chain operations and a justified share of equipment costs. Divide by the completed service you intend to measure, not by bookings or purchased doses. Costing supports planning; it must never decide whether a questionable product is safe to use.

By Bractis · Updated · 9 min read

Indian clinic owners, paediatric practices and accounts teams planning vaccination or minor-procedure services without confusing purchase spending, resource cost and patient price.

Choose the decision and the unit of service

A new vaccination session raises several different questions: how much cash to buy stock, what a completed administration costs, what resources remain at the end and whether the quoted patient fee covers the service. One number cannot answer all four.

Define the costing unit. It may be one administered dose, one completed dressing or one procedure episode. A booking, a vial, an injection visit and an administered dose are not interchangeable units, especially where a visit includes more than one service.

Use a stated period and perspective. A clinic's cash-spending view includes purchases when paid; a resource-use view considers what was consumed during the service. Identify which view the table represents before comparing it with income.

Distinguish the clinical service from its pricing or GST treatment. A transparent cost calculation does not establish the appropriate tax classification, a permitted charge or the patient's entitlement under a public programme.

For a combined visit, decide how shared resources will be allocated. If the same staff time is charged fully to both the consultation and the vaccination cost model, the clinic has counted it twice.

Reconcile doses before allocating purchase cost

Begin with a stock bridge: opening usable stock, receipts, administrations, approved losses, returns or transfers and closing usable stock. Keep quarantined or uncertain stock in a distinct state until the competent decision is recorded.

Consider a fictional session starting with no stock and receiving 20 single-dose units at ₹600 each. Four remain usable at the end, 14 were administered and two were quarantined. The purchase spending is ₹12,000, but the stock states explain where every unit is.

Do not immediately call the quarantined units waste, and do not count them as available for the next appointment. Their clinical disposition and financial treatment require evidence. Record the outcome before choosing which cost scenario applies.

If the two units are later approved for return to usable stock, six units remain for future use. If they are confirmed as a loss, the period has 14 administrations, two lost units and four usable units remaining. Both scenarios reconcile to the original 20.

Keep batch identity and any supplier credit linked to the physical disposition. A commercial refund does not itself make stock safe, and destroying a product does not prove that the supplier has issued a credit.

Include the work that keeps stock usable

The MoHFW routine-immunisation manual treats cold-chain equipment, monitoring and vaccine-specific handling as substantive work. A cost model should recognise that work without copying public-programme practices indiscriminately into every private-clinic setup.

List the clinic's relevant costs: validated storage arrangements, monitoring, power, maintenance, transport, trained handling and the agreed response to equipment problems. Use actual invoices, time records and service arrangements where available.

Follow the product and applicable programme requirements for storage, reconstitution and open-vial use. A financial model must not invent a universal reuse period, assume every partly used vial can be retained or justify use of stock whose condition is unresolved.

WHO's 2025 wastage-calculator overview distinguishes different wastage categories and service settings. This supports using a reasoned model; it does not supply one correct wastage percentage for every clinic. The example here uses explicit fictional quantities, not a WHO default.

Keep avoidable loss visible so the clinic can investigate its cause. Purchasing, scheduling, cold-chain failure and unused open-vial contents require different responses. Combining them into one percentage may conceal the process that actually needs improvement.

Source: MoHFW: Routine Immunization Manual for Health Workers, 2024

Source: WHO: Vaccine Wastage Rates Calculator

Build a cost per administered dose from stated assumptions

Continue the fictional 20-unit example and assume the two quarantined units become a confirmed loss with no supplier credit. The medicine cost attributed to the session is 16 × ₹600 = ₹9,600. The four usable closing units, worth ₹2,400 on this simple basis, remain outside that session's resource-use cost.

Assume four staff-hours allocated to the session at ₹300 per hour, ₹25 of consumables per administration, ₹200 for operating/transport costs and ₹300 of equipment allocation. These are invented planning inputs, not Indian market prices or suggested fees.

The total is ₹9,600 + ₹1,200 + ₹350 + ₹200 + ₹300 = ₹11,650. Dividing by 14 completed administrations gives approximately ₹832.14 each. Dividing by the 20 purchased units would understate the cost of the completed services being measured.

If the two quarantined units are released to usable stock instead, only 14 units' medicine cost is consumed in this example. The comparable session total becomes ₹10,450, or about ₹746.43 per administration. Do not choose the lower figure until the stock disposition supports it.

The model omits other overheads, taxes and financing costs unless explicitly added. It also assumes the allocated staff time is not counted again elsewhere. State these limits whenever the figure is used in a pricing discussion.

On a narrow screen, scroll the table horizontally to read all columns.

Fictional session resource cost after two units are confirmed lost
ComponentCalculationAmount
Medicine use and loss16 units × ₹600₹9,600
Staff time4 hours × ₹300₹1,200
Consumables14 administrations × ₹25₹350
OperationsAssumed session allocation₹200
EquipmentAssumed session allocation₹300
Total14 completed administrations₹11,650
Per dose given₹11,650 ÷ 14About ₹832.14

Separate planning assumptions from measured cost

An equipment allocation needs a stated basis. Suppose a fictional ₹60,000 asset is spread over 60 months for internal planning: ₹1,000 per month. Assigning 30% to this session gives ₹300. That is a management-cost assumption, not a statutory depreciation rate or a claim about the asset's useful life.

Test sensitivity to completed volume and loss rather than presenting one amount as permanent. Some costs vary with administrations; others remain when fewer patients attend. Recalculate each component rather than dividing every cost by a new appointment count.

Do not optimise the financial denominator by delaying clinically appropriate vaccination until a session is full. Clinical timing, patient access and applicable handling requirements come first. The model can reveal the cost of providing that access without deciding the care plan.

For procedures, replace vaccine-specific inputs with the actual resource bundle: the correct sterile pack, required consumables, staff time, cleaning and equipment use. Count opened but unused items according to their actual disposition and local accounting policy.

Separate a supplier's minimum order or pack size from clinical demand. A lower unit purchase price may increase cash tied up in stock or expiry losses. Compare the expected usable quantity and replenishment needs, not only the discount.

Make the costing sheet maintainable

Assign an owner for each input: stores for quantities, the clinical lead for permitted handling, operations for staff and equipment use, and accounts for cost treatment. An owner should be able to explain the source and date of the number.

Use the model to discuss the actual service offer. A quote should make clear what is included, what may change and how cancellations or unavailable stock are handled. Cost per administration is not automatically the price the patient should pay.

Review exceptions after a session. Did the planned stock match administrations? Did an equipment event quarantine usable-value stock? Were staff-hours different from the assumption? Preserve the explanation so the next estimate improves.

Keep the loss denominator explicit. Two lost units out of 20 acquired are 10% of that acquired cohort. That is not the same as a loss measure restricted to the 16 units used or lost, and neither should be described as a national wastage benchmark.

Use a short reconciliation sheet rather than a cost calculator detached from stock. A reliable total is one that another team member can reproduce from quantities, assumptions and the recorded disposition.

A purchase discount that increases unused stock

A fictional clinic can buy a larger pack at a lower unit price but has no evidence that the additional doses will be used before their applicable expiry or handling limit. It compares the smaller pack's expected usable quantity with the larger pack's cash commitment and credible demand. The clinical team does not change a patient's schedule to improve the spreadsheet. Procurement follows the service plan and stock evidence, with the assumptions recorded.

Vaccine-session costing worksheet

Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.

Cost unit
Are you measuring cash spent, resource cost per completed service or a patient price, and over which period?
Stock disposition
Can every opening and purchased dose be reconciled to administration, usable closing stock, transfer or an approved loss?
Resources
What staff, consumable, operating and equipment costs belong to the service without double counting?
Decision limits
Which assumptions, unresolved quarantines, exclusions and clinical constraints could change the calculation?

Questions doctors ask

Should all purchased vaccine stock be charged to one session's cost?

Not automatically. A resource-use model separates stock consumed or approved as lost from usable closing stock. The cash-spending view may include the full purchase, so label the perspective clearly.

Is quarantined vaccine stock immediately a confirmed loss?

No. It is unavailable pending the competent disposition decision. Keep it separate from both usable stock and approved loss, then update the cost treatment when evidence resolves the status.

What wastage percentage should every private clinic use?

There is no single percentage established by this guide. Use the relevant product, service setting and observed stock outcomes, with an explicit denominator. Do not copy a planning assumption as a clinical handling rule.

Is the calculated cost per dose the recommended patient fee?

No. It is a stated resource-cost estimate. Pricing, service inclusions, taxes and any applicable programme or commercial constraints require separate decisions.

Is the equipment allocation a tax depreciation calculation?

No. The ₹60,000 over 60 months example is a fictional internal planning assumption. Tax treatment and the clinic's accounting policy need their own professional assessment.

Sources and scope

Updated on . This article combines the cited references with Bractis’s original workflow analysis and illustrative examples. Product capabilities depend on the configured scope. No independent clinical or legal review is claimed.

  • WHO: Vaccine Wastage Rates Calculator

    WHO technical overview dated 16 September 2025, checked 25 October 2026. Distinguishes service-setting and wastage categories for planning. The spreadsheet was not run; no WHO default wastage percentage is asserted.

  • MoHFW: Routine Immunization Manual for Health Workers, 2024

    Indian programme manual, relevant primary indexed cold-chain content checked 25 October 2026. Product-specific storage and open-vial decisions are not inferred from a generic clinic cost model.

Try the workflow
with Bractis.

Use fictional quantities to trace usable, quarantined and lost stock alongside service costs in a Bractis walkthrough. Confirm which stock and export features are available; keep product-release decisions with qualified staff.

Request a clinic demo